You are here : Home > News > CEA @CES2022

Media kits | Press kits | News | Multimedia content | Articles & files | Article | Energies | New technologies | Health & life sciences | Biotechnology | Artificial intelligence | Renewable energies

CES 2022

INJECT POWER


Medical implants present a particular challenge when it comes to
power. As implants get smaller, it becomes more difficult to ensure
sufficient energy density for long-term operation. Injectpower solves this problem with an innovative, safe, rechargeable, high energy density, reliable solid-state microbattery technology. It offers unprecedented energy density on an ultra-thin substrate.


Published on 14 December 2021

WHAT IS INJECTPOWER?

​Medical implants present a particular challenge when it comes to power. As  implants get smaller, it becomes more difficult to ensure sufficient energy density for long-term operation.

Injectpower solves this problem with an innovative, safe, rechargeable, high energy density, reliable solid-state microbattery technology. It offers unprecedented energy density on an ultra-thin substrate.

The technology is the result of more than sixteen years of research and development at CEA-Leti, a major international research organization located in France. 

Power management is optimized to extend battery life, enabling the kind of continuous operation required for medical devices.  Testing has confirmed a 1,000-cycle, ten-year lifespan.